期刊文献+

膀胱肿瘤端粒酶活性及细胞凋亡的研究 被引量:5

Telomerase activity and cellular apoptosis of bladder cancer
原文传递
导出
摘要 目的 探讨端粒酶活性及细胞凋亡与膀胱癌临床生物学行为及预后的关系。 方法 分别采用端粒酶活性试剂盒和末端脱氧核苷酸转移酶介导缺口末端标记 (TUNEL)法对 5 6例膀胱癌标本进行端粒酶活性和细胞凋亡的检测 ,并结合临床资料进行分析。 结果  5 6例膀胱癌标本端粒酶活性阳性率为 89 3 % (5 0 / 5 6 ) ,细胞凋亡指数为 (4 5 2± 14 4) % ;端粒酶活性强度及细胞凋亡指数与年龄、性别、肿瘤大小、数目等无关 (P >0 0 5 ) ;与肿瘤分级、分期及预后有关 (P <0 0 1) ,即端粒酶活性越高或 (和 )细胞凋亡越少 ,则肿瘤“瘤级”、“瘤期”高者预后较差。端粒酶活性强度与细胞凋亡指数呈明显的负相关 (r=- 0 6 9,P <0 0 1)。 结论 膀胱癌端粒酶活性及细胞凋亡与肿瘤分级、分期及预后有关 。 Objective[WT5”BZ] To explore the relationship between clinicobiological acting, telomerase activity and cellular apoptosis of bladder cancer. [WT5”HZ]Methods[WT5”BZ] The intensity of telomerase activity and cellular apoptosis of bladder cancer were detected by telomeric repeat amplification protocol(TRAP) and terminal deoxynucleotidyl transferase mediated dUTP biotin nick end labeling (TUNEL) assay respectively. [WT5”HZ]Results[WT5”BZ] The positive rate of telomerase activity of bladder cancer was 89 29% and the apoptosis index of bladder cancer was (45 16±14 43)%.The intensity of telomerase activity and apoptosis index of bladder cancer were not related to patient′s age, sex, size or number of tumor ( P >0 05),but to the“grade”,“stage”and prognosis of bladder cancer( P <0 01). The higher the intensity of telomerase activity or less cellular apoptosis, the poor prognosis of differenciated or more advanced bladder cancer. The intensity of telomerase activity was negatively correlated with cellular apoptosis of bladder cancer( r =-0 69, P <0 01). [WT5”HZ]Conclusions[WT5”BZ] The intensity of telomerase activity and cellular apoptosis are correlated with the grade,stage and prognosis of bladder cancer.The detection of telomerase activity and cellular apoptosis are helpful in clinical analysis and evaluation of prognosis of bladder cancer. [WT5”HZ]
出处 《中华外科杂志》 CAS CSCD 北大核心 2000年第9期697-699,共3页 Chinese Journal of Surgery
基金 吴阶平泌尿外科基金
关键词 膀胱肿瘤 端粒 端粒酶 细胞调亡 生物学行为 WT5”BZ] Bladder neoplasms Telomere Diagnosis Prognosis Apoptosis
  • 相关文献

参考文献1

  • 1秦自科,癌症,1999年,18卷,279页

同被引文献36

  • 1沈杨,任慕兰,蔡云朗,程云英,宋萍.拓扑替康对人卵巢癌细胞株端粒酶活性表达的影响[J].东南大学学报(医学版),2005,24(2):78-81. 被引量:1
  • 2汤睿,朱正纲.凋亡途径与肿瘤治疗[J].世界华人消化杂志,2005,13(20):2469-2472. 被引量:27
  • 3Jian-lun Liu,Lian-ying Ge,Gui-nian Zhang.Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma[J].World Journal of Gastroenterology,2006,12(3):465-467. 被引量:11
  • 4郭建华,崔黎明,李淑红,刘利,赫荣华,刘冰.胡桃楸提取物对S_(180)肉瘤的抑制作用及机制[J].吉林大学学报(医学版),2007,33(2):286-289. 被引量:11
  • 5OmarS, Lemonnier B, Jones N, et al . Antimicrobiai activity of extracts of eastern North American hardwood trees and relation to traditional medicine [J]. J Ethnopharmacol, 2000, 73 (1-2): 161-170.
  • 6Anderson KJ, Teuber SS, Gobeille A, et al. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation [J]. Biochemi Mole Action Nutri, 2001, 131 (11): 2837- 2842.
  • 7Pendino F,Tarkanyi I,Dudognon C.Telomeres and telomerase:Pharmacological targets for new anticancer strategies[J].Curr Cancer Drug Targets,2006,6(2):147-180.
  • 8Cunningham A P,Love W K,Zhang R W,et al.Telomerase inhibition in cancer therapertics:molecularbased app roaches[J].Curr Med Chem,2006,13(24):2875-2888.
  • 9Caplen N J.A new approach to the inhibition of gene expression[J].Trends Biotechnol,2002,20 (2):49-51.
  • 10Reynolds A,Leake D,Boese Q,et al.Rational siRNA design for RNA interference[J].Nat Biotechnol,2004,22(3):326-330.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部